EPHX2
EPHX2 (epoxide hydrolase 2, also known as sEH or ABHD20) is a bifunctional enzyme of the epoxide hydrolase family. It binds specific epoxides and converts them to the corresponding dihydrodiols, and its N-terminal domain also acts as a lipid phosphatase. Browse Assay Genie's current range of EPHX2 research reagents below, or read on for the biology behind the target.
EPHX2 encodes a bifunctional enzyme. The C-terminal activity is that of an epoxide hydrolase: the protein binds to specific epoxides and converts them to the corresponding dihydrodiols. The N-terminal domain is a separate lipid phosphatase. Its highest activity is towards threo-9,10-phosphonooxy-hydroxy-octadecanoic acid, followed by erythro-9,10-phosphonooxy-hydroxy-octadecanoic acid, 12-phosphonooxy-octadec-9Z-enoic acid and 12-phosphonooxy-octadec-9E-enoic acid. The enzyme also has phosphatase activity towards lyso-glycerophospholipids, with lower activity towards lysolipids of sphingolipid and isoprenoid phosphates.
The protein is found in both the cytosol and peroxisomes. It belongs to the AB hydrolase superfamily and the epoxide hydrolase family. HGNC places the gene in the abhydrolase domain containing group and in the HAD Asp-based non-protein phosphatases group, which matches its two catalytic domains. The EPHX2 gene is also known by the aliases sEH and ABHD20. The previous HGNC name was epoxide hydrolase 2, cytoplasmic. Orthologues of the human gene are annotated in mouse and rat, both named Ephx2, so rodent models are commonly used to study it.
Mutations in the EPHX2 gene have been associated with familial hypercholesterolaemia. Alternatively spliced transcript variants have been described. Researchers working on lipid metabolism, epoxide detoxification and lipid phosphate signalling study the EPHX2 protein alongside related family members such as EPHX1, EPHX3 and EPHX4.
EPHX2 binds specific epoxides and converts them to dihydrodiols, making it a focus for studies of epoxide hydrolysis.
The N-terminal domain dephosphorylates lysophospholipids, sphingolipid and isoprenoid phosphates, and phosphonooxy fatty acids, opening a route to lipid phosphate research.
Mutations in the gene have been associated with familial hypercholesterolaemia, so EPHX2 is relevant to genetic studies of lipid disease.
The protein occurs in both the cytosol and peroxisomes, which makes it useful for studying how one enzyme works across compartments.
EPHX2 is a bifunctional enzyme. Its epoxide hydrolase activity converts specific epoxides to the corresponding dihydrodiols. Its N-terminal domain is a lipid phosphatase, active towards phosphonooxy fatty acids and lyso-glycerophospholipids, with lower activity towards sphingolipid and isoprenoid phosphate lysolipids.
EPHX2 stands for epoxide hydrolase 2. The aliases are sEH and ABHD20, and the previous name was epoxide hydrolase 2, cytoplasmic. UniProt lists the protein as bifunctional epoxide hydrolase 2. NCBI notes that alternatively spliced transcript variants have been described.
Mouse and rat both have an orthologous gene called Ephx2. In humans, mutations in EPHX2 have been associated with familial hypercholesterolaemia. Check the datasheet of any product for its validated reactivity.
Other epoxide hydrolase family members with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P34913; product specifications from Assay Genie datasheets.